Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
671 participants
OBSERVATIONAL
2022-09-22
2030-09-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ANGiographic Evaluation of Left Main Coronary Artery INtErvention
NCT04604197
Southeastern Europe Microcirculation Registry
NCT06393478
Portuguese Registry on Interventional Cardiology
NCT01867801
Registry of Secondary Revascularization
NCT03349385
Barts Revascularisation Registry
NCT05255705
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable patients should have complaints of chest pain suspected of angina pectoris or other symptoms raising the suspicion of IHD and non-obstructive epicardial coronary arteries on invasive coronary angiography (ICA, diameter stenosis of less than 50%) with an FFR \>0.80.
* Any other clinical scenario (including in the context of ACS) prompting the physician to assess the function of the coronary microvasculature.
Exclusion Criteria
* Unstable hemodynamics
* Ongoing chest pain.
* Previous CABG
* Moderate to severe valvular heart disease
* Uncontrolled or recurrent ventricular tachycardia.
* Active liver disease or hepatic dysfunction, defined as AST or ALT \> 3 times the ULN.
* Comorbidity with life expectancy \<= 2 years.
* Severe renal dysfunction, defined as an eGFR \<30 mL/min/1.73 m2.
* Subject is currently participating in another investigational drug or device clinical study.
* Presence of other anatomic or comorbid conditions, or other medical, social or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hexacath, France
INDUSTRY
CoreAalst BV
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OLV Ziekenhuis Aalst
Aalst, , Belgium
Righospitalet
Copenhagen, , Denmark
University of Mainz
Mainz, , Germany
Catharina Hospital
Eindhoven, , Netherlands
Radboud Hospital
Nijmegen, , Netherlands
Maasstad Ziekenhuis
Rotterdam, , Netherlands
University Clinical Center of Serbia, University of Belgrade
Belgrade, , Serbia
University Hospital Puerta del Mar
Cadiz, , Spain
Clinica La Princesa
Madrid, , Spain
San Carlos Hospital
Madrid, , Spain
University Hospital Lausanne
Lausanne, , Switzerland
Royal United Hospital Bath NHS Foundation Trust
Bath, , United Kingdom
Bristol Heart Institute
Bristol, , United Kingdom
Basildon Hospital
Essex, , United Kingdom
Golden Jubilee National Hospital
Glasgow, , United Kingdom
Imperial College
London, , United Kingdom
Royal Brompton Hospital
London, , United Kingdom
St. Thomas Hospital, King's College
London, , United Kingdom
Oxford University Hospitals
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRI-080
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.